CoChat

Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus: Table 1

Open access
Lin, Lin, Ibrahim, Ashraf S., Baquir, Beverlie, Avanesian, Valentina, Fu, Yue, Spellberg, Brad · 2009 · FEMS Immunology & Medical Microbiology
Cited by 29

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Dear Editor, We have reported that a vaccine based on the recombinant N-terminus of the candidal surface adhesin, Als3p (rAls3p-N), induced cross-kingdom protection against otherwise lethal intravenous infection caused by the bacterium, Staphylococcus aureus (Spellberg et al., 2008). Vaccine efficacy was mediated by CD3 lymphocytes, predominantly with a T helper type 1 (Th1) phenotype; humoral immunity was neither necessary nor sufficient to mediate protection. Nevertheless, because Th1 cells do provide help to B cells and stimulate production of antibody, and antibody titers are elevated even during polarized type 1 immune responses (Mosmann et al., 1986; Smith et al., 2000), we hypothesized that antibody titers could serve as surrogate markers of protection for the rAls3p-N vaccine, despite the fact that the vaccine mediates protection by inducing cell-mediated immunity. To determine the potential for antibody titers to serve as accurate surrogate markers of protection for our anti-S. aureus vaccine, we studied serum banked from 32 mice vaccinated and infected in the previously published study (Spellberg et al., 2008). Antibody titers were determined by enzyme-linked immunosorbent assay, as previously described (Spellberg et al., 2005,; 2006), and compared with the known time to death from infection. A single dose of vaccine plus 0.1% aluminum hydroxide adjuvant [Al(OH)3] resulted in a >20-fold increase in median titers of both total immunoglobulin G (IgG) and IgG2a antibodies compared with Al(OH)3 alone (IgG titers=1 : 4800 vs. 1 : 200; IgG2a titers=1 : 1600 vs. 1 : 50, P<0.01 for both comparisons). Two doses of vaccine resulted in an additional 10-fold rise in median titers of IgG antibodies [IgG titers=1 : 51 200 vs. 1 : 200; P<0.01 vs. both Al(OH)3 alone and one dose of vaccine]. Surviving vaccinated and adjuvant control mice had higher anti-rAls3p-N IgG (12 800 vs. 200; P=0.03) and IgG2a (3200 vs. 200; P=0.002) titers than those that died from infection. However, IgG titers were similar between vaccinated mice (exclusive of adjuvant control mice) that did or did not survive subsequent infection (25 600 vs. 25 600; P=0.9). Furthermore, there was no correlation between individual IgG antibody titers and time to death when comparing all mice (ρ=0.2, P=0.1), all vaccinated mice [including both one and two doses of rAls3p-N plus Al(OH)3] (ρ=0.01, P=0.7), or in mice vaccinated with one dose (ρ=0.2, P=0.4) or with two doses (ρ=−0.2, P=0.99). In contrast, in vaccinated mice (exclusive of adjuvant control mice) anti-rAls3p-N IgG2a titers were higher in survivors than nonsurvivors (4800 vs. 800; P=0.01). Furthermore, IgG2a titers correlated with time to death (ρ=0.4, P=0.02), even when excluding adjuvant control mice and analyzing only mice vaccinated with either one or two doses (ρ=0.7, P=0.003), or mice vaccinated with one dose (ρ=0.7, P=0.049), or with two doses (ρ=0.8, P=0.02) of rAls3p-N plus Al(OH)3. Similarly, the ratio of IgG2a/IgG antibody titers in individual mice vaccinated with rAls3p-N plus Al(OH)3 was higher in survivors than nonsurvivors (median ratio=0.5 vs. 0.03; P=0.049). IgG2a/IgG ratios correlated with time to death when analyzing just mice vaccinated with either one or two doses (ρ=0.5, P=0.02), or in mice vaccinated with one dose (ρ=0.8, P=0.03), or with two doses (ρ=0.8, P=0.02) of rAls3p-N plus Al(OH)3. No IgG titer had a positive or negative predictive value, or overall accuracy, of >70%, at predicting survival in vaccinated mice (exclusive of adjuvant control mice) (Table 1). In contrast, an IgG2a titer of ≥3200 had 86% positive and negative predictive values, and an overall accuracy of 86% for survival. An IgG2a titer of ≥1 : 6400 had 100% positive predictive value for survival, but the negative predictive value fell to 64%, resulting in an overall accuracy of 73%. Accuracy of antibody titer cut-offs for predicting survival in mice vaccinated with one or two doses of rAls3p-N+Al(OH)3 and infected with Staphylococcus aureus No vaccinated mice had titers <1600; hence, the NPV=0/0. Sensitivity, number of surviving mice with titers greater than or equal to the cut-off/number of all surviving mice; specificity, number of mice that died with titers less than the cut-off/number of all mice that died; PPV, positive predictive value, which is the percentage of mice with titers greater than or equal to the cut-off that survived; NPV, negative predictive value, which is the percentage of mice with titers less than cut-off that died; accuracy=[(number of mice with titers greater than or equal to the cut-off that survived infection)+(number of mice with titers less than the cut-off that died from infection)/(all mice)]. NA, not applicable. Accuracy of antibody titer cut-offs for predicting survival in mice vaccinated with one or two doses of rAls3p-N+Al(OH)3 and infected with Staphylococcus aureus No vaccinated mice had titers <1600; hence, the NPV=0/0. Sensitivity, number of surviving mice with

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1574-695x.2008.00531.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 29

Metadata

Authors
Lin, L., Ibrahim, A. S., Baquir, B., Avanesian, V., Fu, Y., & Spellberg, B.
Venue
FEMS Immunology & Medical Microbiology
Published
2009-04
Volume
55
Issue
3
Pages
293-295
ISSN
  • 0928-8244 (ISSN-L)
  • 1574-695X
OpenAlex
W2042686220
Cited by
29
References
4
FWCI
2.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus: Table 1. https://app.cochat.ai/papers/10.1111/j.1574-695x.2008.00531.x
The paper
Lin, L., Ibrahim, A. S., Baquir, B., Avanesian, V., Fu, Y., & Spellberg, B. (2009). Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus: Table 1. FEMS Immunology & Medical Microbiology. https://doi.org/10.1111/j.1574-695x.2008.00531.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.